
Switzerland shows sustained growth of biotech sector
Capital investments in Swiss biotech companies reached the second-best amount ever with CHF3.33bn in the second year of the pandemic, according to...

French ImCheck get´s a USD103m check by Pfizer and a pack of VCs
With around EUR100m in previous financing rounds ImCheck’s financial position looks 'solidified' to take on the leadership in the gamma-delta T cell...

Orphan drug developer Minoryx raises €51m
The Series C round was co-led by Columbus Venture Partners and Caixa Capital Risc, and supported by CDTI Innvierte, Fund+, Ysios Capital and other...

Meat consumption must fall by at least 75 percent
The study from lead author Prof. Dr Matin Qaim reviews the current state of research on various aspects of meat consumption. In addition to the...

Roche obtains special authorisation for bispecific antibody
Roches new developed immunotherapy is based on a bispecific antibody, which targets B-lymphocyte antigen CD20 and the CD3-T-cell receptor at the...

Vigeneron updates gene therapy collab with Daiichi Sankyo
Under the new agreement, Planegg-based AAV specialist ViGeneron GmbH will provide its novel engineered recombinant adeno-associated virus vectors...

Scientists print 3D cancer model
Using a bio-ink made from alginate and human cells, researchers at the Technical University of Berlin have 3D printed a model of a cancer metastasis...